Avalo Therapeutics develops antibody treatments for inflammatory diseases, with its main candidate in clinical trials for hidradenitis suppurativa. It last closed at $6.76 on Nov 20, up 0.15% on the day. The next earnings report for AVTX is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, AVTX reported EPS of -$0.34. Over its last 8 reports the stock moved an average of 2.8% the session after earnings. Over the last 12 months AVTX insiders bought $0 of stock on the open market and sold $8.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is AVTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AVTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AVTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AVTX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 6% below its 20 day and 66% below its 50 day average. It is 128% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 33), near oversold. The nearest support is the Pivot S1 at $6.57, and the nearest resistance the Pivot at $6.80.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 11.0%/day
Key levels
$24.2752 week high+259.0%
$15.43200 day average+128.3%
$15.14100 day average+124.0%
$11.2150 day average+65.8%
$7.71Swing high (Oct 29)+14.1%
$7.1820 day average+6.2%
$6.99Pivot R1+3.4%
$6.80Pivot+0.6%
$6.76Last close
$6.57Pivot S1−2.8%
$6.5352 week low−3.4%
$6.53Swing low (Nov 6)−3.4%
Indicators
RSI (14)
33.11
Weak, oversold below 30
Neutral
MACD
-1.17
Above its signal line
Bullish
Stochastic
10.2
Near the bottom of its range
Oversold
ADX (14)
39.8
Trending down
Williams %R
-88.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-85.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−2.5%
Change over 10 sessions
Bearish
ATR (14)
$0.75
Typical daily range, 11.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 35.7%/day
Key levels
$24.2752 week high+259.0%
$15.43200 day average+128.3%
$15.14100 day average+124.0%
$11.2150 day average+65.8%
$7.71Swing high (Oct 29)+14.1%
$7.1820 day average+6.2%
$6.99Pivot R1+3.4%
$6.80Pivot+0.6%
$6.76Last close
$6.57Pivot S1−2.8%
$6.5352 week low−3.4%
$6.53Swing low (Nov 6)−3.4%
Indicators
RSI (14)
29.14
Oversold below 30
Oversold
MACD
-2.51
Below its signal line
Bearish
Stochastic
4.3
Near the bottom of its range
Oversold
ADX (14)
27.6
Trending down
Williams %R
-98.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-128.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−58.1%
Change over 10 sessions
Bearish
ATR (14)
$2.41
Typical daily range, 35.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AVTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AVTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow AVTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AVTXHow many large options trades hit AVTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AVTX in the last 90 days.
From SEC Form 4 filings by AVTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AVTX is in one of them and how their past AVTX trades turned out.
Avalo Therapeutics is a biotechnology company based in Wayne, Pennsylvania that develops treatments for inflammatory diseases driven by the immune system. Its main drug candidate, abdakibart, is an antibody that blocks IL-1β, a protein that fuels inflammation. The drug is in a Phase 2 clinical trial for hidradenitis suppurativa, a chronic skin condition that causes painful nodules and abscesses, and it is not yet approved for sale. Its intended customers are patients and the doctors who treat them.